Neurovascular Diagnostics
Neurovascular Diagnostics: Innovating low-cost blood tests for unruptured brain aneurysms detection.
Founded
2016Neurovascular Diagnostics: Innovating low-cost blood tests for unruptured brain aneurysms detection.
Neurovascular Diagnostics, founded with the mission to revolutionize brain aneurysm detection, focuses on developing a low-cost blood test for unruptured brain aneurysms. The company aims to make aneurysm screening more accessible and affordable, enabling physicians to implement cost-effective preventative measures. Their innovative diagnostic tool is designed to provide millions of Americans with access to early detection, ultimately improving patient outcomes through personalized medicine.
Key figures associated with Neurovascular Diagnostics include a team of experts in medical diagnostics and healthcare innovation. The company has made significant strides in reducing the costs associated with aneurysm detection, positioning itself as a leader in preventative healthcare solutions. By offering an affordable and effective screening method, Neurovascular Diagnostics has the potential to significantly impact public health by preventing aneurysm ruptures and reducing associated healthcare costs.
Companies similar to Neurovascular Diagnostics include ZelosDx, Arterial Health International, Babson Diagnostics and VasoGnosis.
Neurovascular Diagnostics was founded in 2016.
Neurovascular Diagnostics' headquarters is located in Buffalo, NY, US.
Neurovascular Diagnostics' most recent funding round was for $750k (USD) in August 2019.
As of Aug 14, 2019, Neurovascular Diagnostics has disclosed funding of $974k (USD). Undisclosed round amounts are excluded.
Neurovascular Diagnostics has 8 employees as of Feb 4, 2024.
VasoGnosis
